Low-dose continuous infusion 5-fluorouracil combined with weekly leucovorin, nab-paclitaxel, oxaliplatin, and bevacizumab for patients with advanced pancreatic cancer: A pilot study. Background: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback